ARCHIVES

NCI To Use Technology Transfer Agreement To Privatize Journal In A Five-Year Deal

This article is from The Cancer Letter archive.

Vol. 21 No. 46 | December 1, 1995

Download PDF Visit The Full Archive

Related Articles

ODAC Finds Increase In Progression-Free Survival Unconvincing To Approve sNDA For Gemzar In Advanced Ovarian Cancer.

March 24, 2006

Iressa May Benefit Some Breast Cancer, Studies Find

December 27, 2002

Program Project Scores Have Compressed Review Shuld Return To Rank Order; Broder

October 2, 1992

CCIRC Disapproves NCOG Renewal, But Carter Plan Appeal To NCAB; Setback For NCI On Regional Groups

March 6, 1981

FDA Approves Xeloda For Breast Cancer After Failure Of Anthracycline Treatment.

September 28, 2001

Grantees Seek $433.5 Million for construction

November 17, 1978